Axi-cel improved event-free survival in relapsed/refractory large B-cell lymphoma ExpertDr Frederick Locke, Moffitt Cancer Cancer, Tampa, Florida, USA TrialPhase 3, ZUMA-7 ConferenceASH 2021 TypeNews article 4 February 2022 10:10